Year: 2021
Type: article
Abstract: The intestinal microbiota is a new promising avenue in cancer immunotherapy, but mechanisms remain elusive. He et al. demonstrate that butyrate, a bacterial metabolite, enhances the CD8+ T cell response and improve chemotherapy efficacy through ID2-dependent IL-12 signaling.
Source: Cell Reports Medicine
Authors: Camille Danne, Harry Sokol
Institutions: AgroParisTech, Microbiologie de l’alimentation au service de la santé, Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine, Institut National de la Recherche Agronomique, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Centre de Recherche Saint-Antoine
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,200
OpenAlex ID: W3182490035
